PDRN Facial Rejuvenation

PDRN (polydeoxyribonucleotide) facial rejuvenation is an advanced regenerative injectable derived from a highly purified polynucleotide complex of biological origin. PDRN activates adenosine receptors in the skin, directly stimulating fibroblast activity, collagen synthesis, and cellular repair at the molecular level. The result is a progressive improvement in skin quality — refined texture, improved elasticity, reduced fine lines, and a brighter, more hydrated complexion that builds gradually over several weeks.

PDRN is administered through a series of micro-injections across the face using very fine needles, with topical numbing applied for comfort. Sessions take approximately 45–60 minutes, and mild redness or minor bruising at injection sites typically resolves within 24–48 hours. Results develop over 4–6 weeks as collagen production increases. Most patients undergo an initial series of 3 sessions spaced 2–4 weeks apart for optimal outcomes, with maintenance treatments every 3–6 months to sustain results.

PDRN is ideal for patients seeking measurable skin quality improvement without adding volume or altering facial structure — particularly those experiencing early aging signs, dullness, dehydration, or fine lines. It is safe for all skin tones and types, and is frequently recommended alongside microneedling or laser treatments to enhance healing and outcomes. Patients drawn to evidence-based regenerative medicine will find PDRN a well-researched option with strong clinical backing from both Asian and European aesthetic literature.